163 related articles for article (PubMed ID: 37549775)
1. Qualitative Analysis of Patient Perspectives of Buprenorphine After Transitioning From Long-Term, Full-Agonist Opioid Therapy Among Veterans With Chronic Pain.
Edmond SN; Wesolowicz DM; Snow JL; Currie S; Jankelovits A; Chhabra MS; Becker WC
J Pain; 2024 Jan; 25(1):132-141. PubMed ID: 37549775
[TBL] [Abstract][Full Text] [Related]
2. Patient and Provider Perspectives on Benefits and Harms of Continuing, Tapering, and Discontinuing Long-Term Opioid Therapy.
Nevedal AL; Timko C; Lor MC; Hoggatt KJ
J Gen Intern Med; 2023 Jun; 38(8):1802-1811. PubMed ID: 36376623
[TBL] [Abstract][Full Text] [Related]
3. Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings.
Frost MC; Soyer EM; Achtmeyer CE; Hawkins EJ; Glass JE; Hallgren KA; Williams EC
Addict Sci Clin Pract; 2023 May; 18(1):26. PubMed ID: 37143162
[TBL] [Abstract][Full Text] [Related]
4. Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphine.
Daitch J; Frey ME; Silver D; Mitnick C; Daitch D; Pergolizzi J
Pain Physician; 2012 Jul; 15(3 Suppl):ES59-66. PubMed ID: 22786462
[TBL] [Abstract][Full Text] [Related]
5. Outcomes in Long-term Opioid Tapering and Buprenorphine Transition: A Retrospective Clinical Data Analysis.
Sturgeon JA; Sullivan MD; Parker-Shames S; Tauben D; Coelho P
Pain Med; 2020 Dec; 21(12):3635-3644. PubMed ID: 32163149
[TBL] [Abstract][Full Text] [Related]
6. Buprenorphine Microdosing Cross Tapers: A Time for Change.
Raheemullah A; Benhamou OM; Kuo J; Lembke A
Int J Environ Res Public Health; 2022 Dec; 19(24):. PubMed ID: 36554317
[TBL] [Abstract][Full Text] [Related]
7. The problem of pain: Additive analgesic effect of tramadol and buprenorphine in a patient with opioid use disorder.
Montalvo C; Genovese N; Renner J
Subst Abus; 2019; 40(2):136-139. PubMed ID: 30835647
[No Abstract] [Full Text] [Related]
8. Buprenorphine for Pain: A Narrative Review and Practical Applications.
Spinella S; McCarthy R
Am J Med; 2024 May; 137(5):406-413. PubMed ID: 38340973
[TBL] [Abstract][Full Text] [Related]
9. Successful buprenorphine transition while overlapping with a full opioid agonist to treat chronic pain: a case report.
Patel KV; Sahni S; Taylor LF
J Osteopath Med; 2023 Jan; 123(1):1-5. PubMed ID: 36282967
[TBL] [Abstract][Full Text] [Related]
10. Observational Evidence for Buprenorphine's Impact on Posttraumatic Stress Symptoms in Veterans With Chronic Pain and Opioid Use Disorder.
Seal KH; Maguen S; Bertenthal D; Batki SL; Striebel J; Stein MB; Madden E; Neylan TC
J Clin Psychiatry; 2016 Sep; 77(9):1182-1188. PubMed ID: 27035058
[TBL] [Abstract][Full Text] [Related]
11. Continuation of Buprenorphine to Facilitate Postoperative Pain Management for Patients on Buprenorphine Opioid Agonist Therapy.
Mehta D; Thomas V; Johnson J; Scott B; Cortina S; Berger L
Pain Physician; 2020 Mar; 23(2):E163-E174. PubMed ID: 32214293
[TBL] [Abstract][Full Text] [Related]
12. Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis.
Yarborough BJ; Stumbo SP; McCarty D; Mertens J; Weisner C; Green CA
Drug Alcohol Depend; 2016 Mar; 160():112-8. PubMed ID: 26796596
[TBL] [Abstract][Full Text] [Related]
13. Patients' Perspectives on Discontinuing Buprenorphine for the Treatment of Opioid Use Disorder.
Wyse JJ; Eckhardt A; Waller D; Gordon AJ; Shull S; Lovejoy TI; Mackey K; Morasco BJ
J Addict Med; 2024 May-Jun 01; 18(3):300-305. PubMed ID: 38498620
[TBL] [Abstract][Full Text] [Related]
14. Pain Management in Patients With Opioid Use Disorder on Extended-release Buprenorphine: A Case Report.
South AM; Oller D; Lofwall M; Fanucchi LC
J Addict Med; 2024 Jan-Feb 01; 18(1):86-89. PubMed ID: 38039082
[TBL] [Abstract][Full Text] [Related]
15. "Buprenorphine, It Works so Differently": Adults with Sickle Cell Disease Describe Transitioning to Buprenorphine for Treatment of Chronic Pain.
Prince E; Loeser P; Early M; Carroll CP; Lanzkron S; Pecker LH
J Pain; 2024 Mar; 25(3):632-641. PubMed ID: 37742907
[TBL] [Abstract][Full Text] [Related]
16. Chronic opioid pain treatment converted to buprenorphine: A case series using a 3-step low-dose incremental dosing guideline.
Acampora G; Zhang Y
J Opioid Manag; 2024; 20(1):51-56. PubMed ID: 38533715
[TBL] [Abstract][Full Text] [Related]
17. Chronic pain, craving, and illicit opioid use among patients receiving opioid agonist therapy.
Tsui JI; Lira MC; Cheng DM; Winter MR; Alford DP; Liebschutz JM; Edwards RR; Samet JH
Drug Alcohol Depend; 2016 Sep; 166():26-31. PubMed ID: 27422763
[TBL] [Abstract][Full Text] [Related]
18. Patient Barriers and Facilitators to Medications for Opioid Use Disorder in Primary Care.
Tofighi B; Williams AR; Chemi C; Suhail-Sindhu S; Dickson V; Lee JD
Subst Use Misuse; 2019; 54(14):2409-2419. PubMed ID: 31429351
[No Abstract] [Full Text] [Related]
19. Buprenorphine for Chronic Pain Management: a Narrative Review.
Vu PD; Bansal V; Chitneni A; Robinson CL; Viswanath O; Urits I; Kaye AD; Nguyen A; Govindaraj R; Chen GH; Hasoon J
Curr Pain Headache Rep; 2023 Dec; 27(12):811-820. PubMed ID: 37897592
[TBL] [Abstract][Full Text] [Related]
20. Obstetric pain management for pregnant women with opioid use disorder: A qualitative and quantitative comparison of patient and provider perspectives (QUEST study).
Nowakowski E; Dayananda S; Morgan M; Jarvis O; Altamirano V; LaSorda KR; Krans E; Lim G
Addiction; 2023 Jun; 118(6):1093-1104. PubMed ID: 36662775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
